Hostname: page-component-5c6d5d7d68-txr5j Total loading time: 0 Render date: 2024-08-27T20:20:07.590Z Has data issue: false hasContentIssue false

Psychological vulnerability and problematic psychotropic drug use among medical residents: exploring the relationship

Published online by Cambridge University Press:  27 August 2024

H. Ktari
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
S. Sellami*
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
J. Ben Thabet
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
S. Omri
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
R. Feki
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
I. Gassara
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
N. Smaoui
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
L. Zouari
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
M. Maalej
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
M. Maalej Bouali
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
N. Charfi
Affiliation:
Psychiatry C, University Hospital Hedi Chaker, Sfax, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Psychological vulnerability and problematic psychotropic drug use among medical residents are critical and intricate areas of study in the field of healthcare and mental well-being. This topic looks into the potential links between the psychological vulnerabilities experienced by medical residents, which are frequently associated with the demanding nature of their profession, and their use of psychotropic drugs in a way that poses problems or risks. Exploring this relationship is critical for understanding the mental health challenges that medical residents face and developing effective strategies to support their psychological well-being.

Objectives

to identify the psychological factors linked to problematic psychotropic drug use in medical residents.

Methods

We conducted a cross-sectional descriptive and analytical study among Tunisian medical residents between August and September 2022. We used a self-administered questionnaire with a data collection form, the DAST-10 (Drug Abuse Screening Test) scale, and the DASS-21 (Depression, Anxiety, and Stress Scale) in an online survey. Data was analyzed using the 20th version of the SPSS software.

Results

The sample consisted of 80 medical residents. Among them, 23.8% (n=19) had reported a previous use of psychotropic drugs, and 15% (n=12) a misuse (without a prescription and/or without following the prescription). The DAST-10 revealed that 6 residents (31.6%) had problematic use of psychotropic drugs.

A high level of stress on the DASS-21 scale was associated with a problematic use (p=0.01) and a misuse (p=0.01) of psychotropic drugs. Furthermore, residents with high stress levels were more likely to demonstrate problematic use of psychotropic drugs (p=0.004). Such problematic use was correlated with personal history of anxiety disorders (p=0.01).

Furthermore, residents with problematic psychotropic drug use had higher anxiety and depression scores on the DASS-21 scale (p>0.05).

Conclusions

Our findings revealed a concerning prevalence of psychotropic drug use among medical residents and an association with high stress levels. This result emphasizes the need for targeted interventions to support young doctors’ mental health.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.